Dar Bioscience Inc (DARE) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Dar Bioscience Inc   (NASDAQ: DARE)


Dar Bioscience Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Dar Bioscience Inc's ROI in the second quarter of 2026?
Dar Bioscience Inc recorded a cumulative net loss of $-11 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -144.2%.

Within the Healthcare sector 598 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 3710 to 4273.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM - 58.66 % -1.95 % -87.88 % -
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 5 7 9 10 -6
Return On Investment (TTM) -144.2 % -255.91 % -563.57 % -5277.37 % -
DARE's Overall Ranking # 4273 # 3710 # 3773 # 3914 # 0
Seq. Investment Change TTM 62.21 % 97.56 % 683.66 % - -
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -11 -12 -13 -16 -17

DARE Company Profile >> Back to DARE Roi Comparisons >> See Annual DARE Return On Investment



Return On Investment DARE's Ranking
Within: No.
Industry # 268
Sector # 599
Overall # 4273

Return On Investment Statistics
High Average Low
-7.56 %
-481.87 %
-5277.37 %
(Mar 31 2025)   (Sep 30 2025)







Financial Statements
Dar Bioscience Inc's II. Quarter Investments $ 5 Millions DARE's Balance sheet
Dar Bioscience Inc's II. Quarter Income $ -3 Millions Quarterly DARE's Income Statement
DARE's Income by Division See DARE's Income by Division


DARE Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 9 0 1 12 40
Y / Y Investment Growth 1685.88 % -38.62 % -93.43 % -69.31 % -
Net Income in Millions -13 -4 -30 -31 -39
Y / Y Net Income Growth - - - - -
Annual Return On Investment -152.46 % -823.68 % -3761.64 % -253.62 % -97.34 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
DARE's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for DARE's Competitors
Subscribers only: Roi for Dar Bioscience Inc's Suppliers
Subscribers only: Return On Investment for DARE's Customers

Other Ratios
DARE's Roa DARE's Inventory Turnover Ratio DARE's Growth Rates DARE's Dividend Statistics
DARE's Profitability Ratios DARE's Asset Turnover Ratio DARE's Dividend Growth
DARE's Roe DARE's Valuation Ratios DARE's Financial Strength Ratios DARE's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-03T11:42:10+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.